That learned and gentle soul has surfaced, momentarily, in my email box (I just checked the archive box this evening) -- and so, I'll pass this along -- regarding the fourth change of hands, for asenapine, the beleaguered candidate he so eloquently critiqued, over four years ago (now sold as Saphris®):
. . . .Haven’t been following your blog for a while.
I just heard about this even though it occurred 2.5 weeks ago.
See where you predicted it. . . .-- Salmon
Huge surprise. Brent Saunders (another Fast Fred protégé) taking yet another payout, rather than being bothered with the unthinkable drudgery -- of actually running a[nother] company.
And, true to form, he overpaid for the turkey Saphris, then sold it at an additionally inflated price -- to a less-keen buyer.
Predictable. In fact, as Salmon intones -- we both did.
See here -- from the latest SEC filing on that deal:
Be excellent to one another. I'm out -- to the movies -- to see "Hotel Budapest."
No comments:
Post a Comment